Summary of Final Decisions Issued by the Trademark Trial and Appeal Board

                               April 13-17, 1998


                                
Date            Type of         Proceeding                      
Issued          Case (1)        or App'n No.            Party/Parties

4-14            EX              74/421,666              Pingel Enterprise,
                                                        Inc. 

4-14            CANC            26,657                  Wellcome Founda-
                (MD)                                    tion Ltd. v.
                                                        Merck & Co., Inc. 

4-14            OPP             97,778                  Isolab, Inc. v.
                                                        Genzyme Corp.   

                                Opposer's/              Applicant's/
                                Petitioner's            Respondent's
                TTAB            Mark and                Mark and
Issue           Decision        Goods/Services          Goods/Services

de jure         Refusal                                 configuration of a
function-       Affirmed                                fuel valve for 
ality; dis-     (on both                                motorcycles [fuel 
tinctiveness    grounds)                                filters and 
under Sec.                                              valves]     
2(f)   

whether         Motion to                               configuration of 
respondent's    Dismiss                                 an "irregular 
registration    Granted                                 shield-shaped
should be       [Petition                               tablet"
cancelled       to Cancel                               [pharmaceutical
because:        Denied]                                 preparation for 
(1) the draw-                                           use as an anti-
ing does not                                            hypercholesterol-
comport with                                            emic agent]      
current draw-
ing require-
ments and/or
(2) the de-
scription of 
the mark is 
too broad   

2(d);           Opposition      "LDL-DIRECT"            "DIRECT LDL"            
whether op-     Sustained       [blood testing          [diagnostic rea-        
poser's mark                    equipment and rea-      gents for the           
is deceptive-                   gents, including        immunoseparation        
ly misde-                       in vitro choles-        of cholesterol          
scriptive                       terol test kits]        components in           
[2(e)(1)] or                                            vitro]      
deceptive 
[2(a)]

Mark and                                        Citable as
Goods Cited by                                  Precedent
Examining Atty.                                 of TTAB

                                                Yes

                                                Yes

                                                No

(1)EX=EX PARTE APPEAL; OPP=OPPOSITION; CANC=CANCELLATION; CU=CONCURRENT 
USE; (SJ)=SUMMARY JUDGMENT; (R)=REQ. FOR RECONSIDERATION